Fundraising FoxRemedy Pharmaceuticals
New York, US · Delaware corporation · 2 known investors
Find your way into Remedy Pharmaceuticals
Sign up to see every warm intro you have to Remedy Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Remedy Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Remedy Pharmaceuticals is a pharmaceutical company developing Cirara, an investigational drug studied in clinical trials for patients who have suffered a stroke. It focuses on treatments for serious neurological conditions.
Founders & leadership
SJ
SVEN JACOBSONExecutive
Board
DG
DAVID GELIEBTERBoard director
Investors · 2
Broadview Ventureslisted by Broadview VenturesBoston
How we know: Broadview Ventures's portfolio page · a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$10.9M disclosed across 3 rounds · 2011–2015
▶$9.1MraisedDec 2015 · 30 investors · PharmaceuticalsRule 506(b)
▶$9.1MraisedDec 2015 · 30 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- SVEN JACOBSONExecutive Officer, Director
- DAVID GELIEBTERDirector
- Offering amount
- $9.1M
- Amount sold
- $9.1M
- First sale
- Nov 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1MraisedFeb 2014 · 4 investors · PharmaceuticalsRule 506(b)
▶$1MraisedFeb 2014 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- SVEN JACOBSONExecutive Officer, Director
- DAVID GELIEBTERDirector
- Offering amount
- $1.4M
- Amount sold
- $1M
- Sales commissions
- $10.5K
- Placement agents
- PERAZA CAPITAL AND INVESTMENT, LLC
- First sale
- Nov 2013
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$792.5KraisedMar 2012 · 3 investors · PharmaceuticalsRule 506(b)
▶$792.5KraisedMar 2012 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- DAVID M. GELIEBTERDirector
- SVEN JACOBSONExecutive Officer, Director
- Offering amount
- $792.5K
- Amount sold
- $792.5K
- First sale
- Oct 2011
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Remedy Pharmaceuticals.
In the news
Frequently asked questions
- What does Remedy Pharmaceuticals do?
- Remedy Pharmaceuticals is a pharmaceutical company developing Cirara, an investigational drug studied in clinical trials for patients who have suffered a stroke. It focuses on treatments for serious neurological conditions.
- Who are Remedy Pharmaceuticals's investors?
- Remedy Pharmaceuticals's investors include Broadview Ventures, The Vertical Group.
- How much funding has Remedy Pharmaceuticals raised?
- Remedy Pharmaceuticals has disclosed $10.9M raised across 3 rounds.
- Where is Remedy Pharmaceuticals headquartered?
- Remedy Pharmaceuticals is headquartered in New York, US.